Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis-Reference-Cited by-同舟云学术

Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis

Published:2024-01 Issue:1 Volume:165 Page:79-83
ISSN:0012-3692
Container-title:CHEST
language:en
Short-container-title:CHEST

Author:

Shteinberg Michal^ORCID,Sibila Oriol,Stein Nili,Faner Rosa,Jordan Alexander^ORCID,Olvera Nuria,Sivapalan Pradeesh^ORCID,Jensen Jens Ulrik S.^ORCID,Crichton Megan,Marrades Pau,Chalmers James D.,Meyer Christian N.^ORCID,Saliba Walid

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference8 articles.

1. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis;Cosgriff;J Cyst Fibros,2020

2. Prevalence, Severity and mortality associated with COPD and smoking in patients with COVID-19: a rapid systematic review and meta-analysis;Alqahtani;PLoS One,2020

3. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease;Adeloye;Lancet Respir Med,2021

4. Bronchiectasis in Europe: data on disease characteristics from the European Bronchiectasis registry (EMBARC);Chalmers;Lancet Respir Med,2023

5. The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project);Sisó-Almirall;Autoimmun Rev,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 in patients with airways disease: COPD, asthma and bronchiectasis;COVID-19: An Update;2024-09-01

2. Exacerbations of bronchiectasis;European Respiratory Review;2024-07

3. A Nationwide Cohort Study of Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease;CHEST;2024-06

4. Symptoms and medical resource utilization of patients with bronchiectasis after SARS-CoV-2 infection;Frontiers in Medicine;2024-01-08